Combination of technologies could reduce the number of early trial compounds from millions to hundreds, potentially shaving years off the discovery-development programme.
A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists.
The Shapeshifting Inspired Discovery (SID) program decodes the structures of proteins in our cells that scientists suspect may hold the key to new treatments. The program can rapidly analyse the complicated shapes and identify how the proteins might be “shapeshifted” by drugs.
Shapeshifting involves an altogether different and more subtle mechanism than conventional drugs, which stop the proteins working completely. The team behind SID – developed entirely at Strathclyde over the last decade, and now being deployed exclusively in collaboration with US firm Serometrix – will apply it to drug discovery for a wide range of diseases and conditions.
Dr Mark Dufton, of Strathclyde’s Department of Pure and Applied Chemistry, said: “Conventional drug discovery is extremely expensive, time consuming and often heavily reliant on ‘lottery techniques’ to identify useful drugs by chance.
“While this has certainly reaped benefits before, these traditional methods are becoming less fruitful and many new drug candidates found in this way are being abandoned because of toxicity problems and side effects. Drugs that act by shapeshifting work in a much smarter way that is a closer mimic of natural mechanisms for control.
“The ability of SID to predict the scope for ‘shapeshifting’ enables us to probe large, complex biological molecules – which have evolved their intricate shapes over hundreds of millions of years – so that we can analyse where and whether they can be targeted to provide treatments. When targeting is more selective, and the mechanism is smarter, a new generation of better medicines beckons.
“There are thousands of different types of protein in the human system that cooperate and regulate each other so that we can function properly. Nature has evolved a beautifully intricate set of mechanisms that regulate many of our critical functions by simply changing protein shape.
“In simple terms, these ‘shapeshifter’ mechanisms allow the proteins to modulate their biological activity by changing their surface character, rather like tectonic plates moving around the surface of the Earth. The more we understand these mechanisms, the more we can emulate what nature has already developed so elegantly.
“Diseases are often caused by certain molecules in the body being either too active or not active enough – or by them operating in the wrong place at the wrong time. The new technology helps discovery of ‘shapeshifting’ drugs that can carefully adjust these biological molecules, bringing them under control and thus less likely to cause problems.
“We can use this knowledge, in the case of a specific disease, to help a key protein be more or less active when the system is not working optimally on its own.”
Strathclyde Professor of Medicinal Chemistry & Drug Discovery Portal Director, Simon Mackay added: “This is an exciting step towards rapidly and efficiently designing the next wave of innovative pharmaceuticals.”
Dr John Wilson, of Strathclyde’s Department of Computer and Information Sciences, said: “We’ve been able to understand how to optimise the SID algorithm such that it now provides a near real-time, three-dimensional, graphical output that makes it extremely easy for clients to quickly understand where to focus their efforts.”
Serometrix Chief Executive Officer Mike Muehlemann said SID was already yielding promising early leads in the search for potential treatments for hypercholesterolemia – high cholesterol – and cardiovascular disease. He added: “Drug discovery and development represents one of the toughest technical challenges of our times.
“We have partnered with Strathclyde because their SID technology is best-in-class and fits exceedingly well with our own technology. The promise of better pharmaceuticals at lower cost is a lofty goal but it is one we believe we can achieve.
“With this combination of technologies we expect to reduce the number of early trial compounds from millions to hundreds, potentially shaving years off the discovery-development programme. Even though regulatory costs may remain high or escalate, an increased yield has the potential for significant cost reduction in the resulting pharmaceuticals.”
The Latest Bing News on:
Shapeshifting computer program
- Proteus, The Shape-Shifting And Possibly Non-Cuttable Materialon November 17, 2020 at 4:00 pm
The creators have named the material Proteus after the elusive and shape-shifting prophet of Greek mythology who would only share his visions of the future with those who could get their arms ...
- e-Weekly News Briefs June 11-15on November 10, 2020 at 4:00 pm
Canon Virginia also will run a cartridge collection and recycling program for the product ... Displays include plastic blood for use in transfusions and shape-shifting airplanes, among others.
- First evidence uncovered for Lost Lieson October 29, 2020 at 2:42 am
Full motion video continues to make something of a comeback, from Her Story to The Complex to The Shapeshifting Detective, to name just a few of an increasing number of live-action releases in recent ...
- research and developmenton October 27, 2020 at 5:01 pm
The Tactical Assault Kit (TAK) is a map-based software application that enables coordination ... capable of morphing into the likeness of a human face, the most complex shape-shifting structure ever.
- Biennials: The Latest Architecture and Newson October 16, 2020 at 2:00 am
Alfredo Jaar, a recent dropout of the University of Chile's architecture program, walks through the ... sources of kinetic energy to kick-off the shapeshifting processes of urban transformations.
- Acquisition and Contractingon May 27, 2019 at 12:28 pm
Convergence of the Physical and Digital Worlds Researchers envision a day when shape-shifting materials, novel sensors and other interactive technologies replace the flat, insipid computer screen. A ...
- The Next Big Thingon September 20, 2018 at 8:23 pm
It has also developed a training program for human resources executives and others ... But billions of years of evolution have endowed proteins with incredible shape-shifting abilities. They can fold, ...
- Science Fiction Studieson September 10, 2018 at 11:57 am
Thus I am somewhat jealous of Brenda Laurel, who has served to mediate between these two groups for several years at conferences and in her written work (especially useful is The Art of Human-Computer ...
- Lisa’s home video capson December 10, 2017 at 9:47 am
His competition consisted of newly retired CEO, Stu Preissler (Steve Martin), pursuing a lifelong dream, and of chubby Brad Harris (Jack Black), a 36-year-old software engineer still living with ...
- The Tech Investment of the Century: Semiconductors 101on October 11, 2017 at 11:05 am
Unfortunately, the same process that allows this also changes the volume of the silicon as lithium ions pass through it, meaning the battery itself would have to be flexible enough to handle all that ...
The Latest Google Headlines on:
Shapeshifting computer program
The Latest Bing News on:
- AI for Drug Discovery Market Growth Factors, Types and Application by regions from 2020 to 2027on November 27, 2020 at 7:29 am
The report covers the forecast and analysis of the AI for drug discovery market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to ...
- Global drug discovery market to record 8.28% CAGR through 2027on November 26, 2020 at 3:45 pm
Nov 26, 2020 (Market Insight Reports) -- Selbyville, Delaware. Market Study Report LLC: According to the recent research report titled 'GLOBAL DRUG DISCOVERY MARKET 2019-2027', available with Market ...
- New Wave: Enters into Partnership with the University of West Indies, Mona, Jamaica for Medicinal Drug Discoveryon November 26, 2020 at 6:42 am
PRNewswire/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTC: TRMND) an investment issuer that provides capital and support services, announced it has entered into ...
- Lantern: Early Stage 'Smart Drug' Discovery Companyon November 25, 2020 at 2:46 pm
Lantern works at the intersection of Artificial Intelligence, Genomics, and Machine Learning. It discovers novel oncology assets using its platform.
- COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Computer Aided Drug Discovery Market?on November 24, 2020 at 1:43 am
Research Dive :The coronavirus outbreak is predicted to impact the global computer aided-drug discovery market in a positive way. The ligand-based drug design segment (LBDD) is estimated to hold a ...
- Computer-Aided Drug Discovery Market Growth Rate and Opportunities in 2027 | BOC Sciences, BioDuro, Schrödinger, Aris Pharmaceuticalson November 24, 2020 at 1:43 am
Research Dive :According to a study conducted by Research Dive, the global computer-aided drug discovery market forecast size is expected to reach $4,878.5 billion by the end of 2026, registering 15.5 ...
- Schrödinger inks multi-target drug discovery deal with Bristol-Myers Squibbon November 23, 2020 at 8:52 am
(NASDAQ:SDGR) jumps 7% premarket on collaboration with Bristol-Myers Squibb (NYSE:BMY) to discover, develop, and commercialize therapeutics in multiple disease areas.
- Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibbon November 23, 2020 at 3:30 am
Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery collaboration with Bristol Myers Squibb Company ...
- Understanding ion channel inhibition to open doors in drug discoveryon November 23, 2020 at 2:03 am
Scientists have discovered how drug-like small molecules can regulate the activity of therapeutically relevant ion channels—and their findings could transform ongoing drug development efforts.
- In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysison November 21, 2020 at 2:12 pm
Roots Analysis has announced the addition of “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and ...